PL BioScience
PrivateLast Round
Series A
Aug 12, 2024
Total Funding Raised
$13.06M
Company Overview
PL BioScience is a biotechnology company that develops and manufactures animal-free cell culture media, specifically Human Platelet Lysate (HPL), for use in regenerative medicine, cell therapy, and biopharmaceutical research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PL BioScience Comparables
Compare PL BioScience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mill Creek Life Sciences | 87% | |
| AventaCell BioMedical Corp. | 86% | |
| Compass Biomedical | 84% |
PL BioScience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 12, 2024 | ||||
| Seed | May 21, 2021 |
Key People
Founding team and executive leadership
PL BioScience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BORN2GROW | Seed |
| Better Ventures | Series A |
| better ventures | Series A |
| Born2grow | Seed |
| Tech Vision Fonds | Series A |
| Brightlands Venture Partners | Series A, Seed |
| Federal Ministry for Economic Affairs and Energy | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 20, 2026
Exclusive agreement with Summit Pharmaceuticals International Corporation for the Japanese market.
- Dec 22, 2025
Added Iwai Chem, a chemicals/life sciences distributor, as a customer.
Recent news
Latest coverage and updates
- hiresJun 17, 2026
PL BioScience GmbH hires Maik W. Jornitz as Board of Directors.
PL BioScience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about PL BioScience's valuation, stock price, and market status.
Is PL BioScience a public or private company?
PL BioScience is a private company.
What is the current stock price of PL BioScience?
PL BioScience is a private company with no public stock price. No recent secondary market data is available.
How much is PL BioScience worth (valuation)?
Valuation information for PL BioScience is not publicly available.
Can I buy PL BioScience stock?
PL BioScience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was PL BioScience's last funding round?
PL BioScience's most recent funding round was Series A on August 8, 2024.
Who are the main investors in PL BioScience?
Key investors in PL BioScience include Better Ventures, b.value AG, AVANT BIO.
Will PL BioScience IPO soon?
No public IPO plans have been announced for PL BioScience.
How can I track PL BioScience secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PL BioScience's secondary market activity and sign up for updates.